Criteria Caixa, S.A.U. Pfizer Inc Call Options Transaction History

Criteria Caixa, S.A.U.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Mar 18, 2025	BUY	$41.75 - $54.5 $582,830 - $760,820	13,960 Added 34900.0%	14,000 $717 Million
Q4 2021 Mar 18, 2025	SELL	$41.32 - $61.25 $1.65 Million - $2.45 Million	-39,960 Reduced 99.9%	40 $2.36 Billion
Q3 2021 Mar 18, 2025	BUY	$39.25 - $50.42 $942,000 - $1.21 Million	24,000 Added 150.0%	40,000 $1.72 Billion
Q3 2020 Mar 18, 2025	BUY	$31.75 - $37.25 $508,000 - $596,000	16,000 New	16,000 $587 Million

3,377

3.55B

106M

123M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Criteria Caixa, S.A.U., based on Form 13F filings with the SEC.

Stay updated on Criteria Caixa, S.A.U. with notifications on news.